Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 3:59 PM
5.98
1.36%
After-hours: Aug 15, 2025, 04:00 PM EDT

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-10.54M -11.65M -12.51M -11.53M -10.12M -8.97M -8.04M -7.53M -8.17M -9.17M -9.68M -10.52M -9.78M -8.38M -7.86M -5.79M -4.62M -4.09M
Interest Income
209.7K 192.7K 225.78K 262.29K 302.56K 278.97K 247.22K 203.44K 132.16K 101.11K 63.57K 21.49K n/a n/a n/a n/a n/a n/a
Pretax Income
-10.33M -11.46M -12.29M -11.27M -9.82M -8.69M -7.79M -7.33M -8.04M -9.07M -9.61M -10.49M -9.78M -8.38M -7.9M -5.75M -4.63M -4.12M
Net Income
-10.33M -11.46M -12.29M -11.27M -9.82M -8.69M -7.79M -7.25M -7.91M -8.94M -9.48M -10.45M -9.78M -8.38M -7.9M -5.75M -4.63M -4.12M
Selling & General & Admin
4.05M 3.77M 4.31M 4.39M 4.47M 4.49M 3.97M 3.71M 3.69M 3.92M 4.02M 4.64M 4.66M 4.01M 4.4M 3.33M 2.84M 2.76M
Research & Development
6.49M 7.88M 8.2M 7.15M 5.65M 4.48M 4.07M 3.82M 4.47M 5.25M 5.65M 5.87M 5.12M 4.37M 3.46M 2.46M 1.78M 1.33M
Other Expenses
706.00 1.07K 1.07K 1.07K 383.00 23.00 23.00 23.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
10.54M 11.65M 12.51M 11.53M 10.12M 8.97M 8.04M 7.53M 8.17M 9.17M 9.68M 10.52M 9.78M 8.38M 7.86M 5.8M 4.62M 4.09M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 45.57M 45.57M 45.57M 45.61M 84.09K 140.77K 167.81K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.77M 11.65M 12.51M 11.53M 10.12M 8.97M 8.04M 7.53M 8.17M 9.17M 9.68M 10.52M 9.78M 8.38M 7.86M 5.8M 4.62M 4.09M
Income Tax Expense
n/a n/a n/a -2.22K -4.03K -5.76K -5.76K -87.72K -128.88K -127.15K -127.15K -45.61M -45.57M -45.57M -45.57M -243 -162 -81
Shares Outstanding (Basic)
1.03M 515.5K 155.5K 155.5K 67.66K 44.41K 393.1K 21.26K 270.5K 6.57K 77.01K 5.12K 69.97K 52.05K 835.2K 31.13K 46.97K 52.05K
Shares Outstanding (Diluted)
1.03M 515.5K 155.5K 155.5K 67.66K 44.41K 393.1K 21.26K 18.03K 6.57K 77.01K 5.12K 4.66K 52.2K 835.2K 31.13K 46.97K 52.05K
EPS (Basic)
-46.93 -87.09 -153.2 -138.2 -198.66 -251.14 -521.36 -536.56 -929.7 -1.42K -1.88K -1.86K -3.45K -3.29K -3.16K -3.15K -1.1K -912.98
EPS (Diluted)
-46.93 -87.09 -153.2 -138.2 -198.66 -251.14 -521.36 -536.56 -929.7 -1.42K -1.88K -1.86K -3.45K -3.29K -3.16K -3.15K -1.1K -912.98
EBITDA
-10.49M -11.6M -9.26M -8.24M -6.83M -5.68M -7.96M -7.53M -8.17M -9.17M -9.68M -10.52M -9.78M -8.38M -7.86M -5.66M -4.49M -3.95M
EBIT
-8.72M -11.6M -12.46M -11.45M -10.03M -8.85M -7.92M -7.46M -8.1M -9.13M -9.63M -10.52M -9.78M -8.38M -7.86M -5.79M -4.62M -4.09M
Depreciation & Amortization
n/a 2.88M 6.09M 6.09M 7.9M 6.75M 3.54M 3.5M 4.14M 5.13M 7.92M 7.96M 5.52M 2.79M 324.00 133.84K 186.5K 186.42K